Axiscades Technologies Ltd — Q4 FY26 earnings call
Summary generated by AI from the official transcript Axiscades Technologies Ltd filed with BSE on 04 Jun 2026. Every statement cites a verbatim quote from that document — open any citation to read it. This is a record of what management said, not a recommendation. How we check these summaries
The short read
AXISCADES reported FY26 revenue growth of 12.4% and EBITDA growth of 24.6% with margin expansion to 15.3%, while Q4 results were affected by a revenue recognition deferment, portfolio restructuring costs, and a higher tax base. Management explained that 142 crores of Q4 revenue shifted into FY27 due to supply chain disruptions and a divestment-related transition, and that reported PAT declined 4.3% year-on-year despite operating growth. The company also detailed a divestment of its heavy engineering, energy, and automotive practice to Akkodis, the creation of a new subsidiary called Xida Inc, and capacity investments in Devanahalli and Hyderabad.
Numbers mentioned
Revenue: 1,159 crores (FY26)
p. 5
“Revenue was at 1,159 crores (12.4% growth year-on-year)”
Mr. Shashidhar S.K., page 5 of the filed PDF · View the filing
EBITDA: 178 crores (FY26)
p. 5
“EBITDA was at 178 crores (24.6% growth year-on-year) with margins at 15.3%, which is 150 bps more than last year”
Mr. Shashidhar S.K., page 5 of the filed PDF · View the filing
PBT before exceptional items: 125 crores (FY26)
p. 5
“PBT before exceptional items was 125 crores (36.5% growth year-on-year)”
Mr. Shashidhar S.K., page 5 of the filed PDF · View the filing
PBT after exceptional items: 114 crores (FY26)
p. 5
“PBT after exceptional items was 114 crores (29.8% growth year-on-year)”
Mr. Shashidhar S.K., page 5 of the filed PDF · View the filing
Normalized PAT: 83 crores (FY26)
p. 5
“Normalized PAT came at 83 crores (27.6% growth) versus normalized FY25 PAT of 65 crores”
Mr. Shashidhar S.K., page 5 of the filed PDF · View the filing
Reported PAT: 72 crores (FY26)
p. 5
“The reported PAT at 72 crores showed a 4.3% degrowth year-on-year, which we will explain”
Mr. Shashidhar S.K., page 5 of the filed PDF · View the filing
Reported revenue: 273 crores (Q4 FY26)
p. 5
“For Q4 specifically, reported revenue was 273 crores, EBITDA was 34 crores, pre-exceptional PBT was 14 crores, and PAT was at 0.4 crores”
Mr. Shashidhar S.K., page 5 of the filed PDF · View the filing
Q4 revenue deferment: 142 crores (Q4 FY26)
p. 5
“First, the Q4 revenue recognition shift of 142 crores, which carried an EBITDA impact of more than 40 crores”
Mr. Shashidhar S.K., page 5 of the filed PDF · View the filing
Exceptional items: 11.17 crores (FY26)
p. 5
“Regarding Factor 2 - exceptional items of 11.17 crores - on May 26th, 2026, AXISCADES signed definitive agreements to divest the heavy engineering, energy, and automotive practice to”
Mr. Shashidhar S.K., page 5 of the filed PDF · View the filing
Tax charge: 42 crores (FY26)
p. 6
“Regarding the tax charge, FY26 was 42 crores against 12 crores in FY25”
Mr. Shashidhar S.K., page 6 of the filed PDF · View the filing
Closing receivables / DSO: 411 crores / 130 days (FY26 close)
p. 6
“Regarding the balance sheet, closing receivables were 411 crores with a DSO of 130 days”
Mr. Shashidhar S.K., page 6 of the filed PDF · View the filing
Gross borrowings: 276 crores (FY26 close)
p. 6
“Gross borrowings increased by 87 crores to 276 crores for project-specific working capital for land systems; this retires as invoices are issued”
Mr. Shashidhar S.K., page 6 of the filed PDF · View the filing
Core domain revenue: 904 crores (78% of consolidated revenue) (FY26)
p. 6
“the core domains of aerospace, defense, and ESAI generated 904 crores in revenue (78% of consolidated revenue)”
Mr. Shashidhar S.K., page 6 of the filed PDF · View the filing
Aerospace revenue: 388 crores (21% growth), 17.3% EBITDA margin (FY26)
p. 6
“Aerospace: 388 crores revenue (21% growth) with 17.3% EBITDA margin.”
Mr. Shashidhar S.K., page 6 of the filed PDF · View the filing
Defense revenue: 379 crores (25% growth), 22.9% EBITDA margin (FY26)
p. 6
“Defense: 379 crores revenue (25% growth) with 22.9% EBITDA margin.”
Mr. Shashidhar S.K., page 6 of the filed PDF · View the filing
ESAI revenue: 136 crores (9% growth), 26.1% EBITDA margin (FY26)
p. 6
“ESAI: 136 crores revenue (9% growth) with 26.1% EBITDA margin.”
Mr. Shashidhar S.K., page 6 of the filed PDF · View the filing
What management said it would do
A record of statements made on the call, in the words management used. Parakho does not forecast, endorse or assess them, and their presence here is not a view on whether they will happen.
FY27 consolidated revenue — 1,377 crores · FY27
stated firmly by Mr. Shashidhar S.K.
p. 6
“Consolidated FY27 revenue is trending towards 1,377 crores (52% growth on the retained business base)”
Mr. Shashidhar S.K., page 6 of the filed PDF · View the filing
FY30 revenue target — 9,000 crores · FY2030
stated firmly by Dr. Sampath Ravinarayanan
p. 3
“We set out on PAR 930 with a clear, non-negotiable target of 9,000 crores of revenue by FY2030”
Dr. Sampath Ravinarayanan, page 3 of the filed PDF · View the filing
EBITDA margin improvement — 150 to 200 bps improvement · year-on-year
stated as an aspiration by Mr. Shashidhar S.K.
p. 6
“What remains are the core verticals where the average EBITDA is already at 20% plus, and we aim for a 150 to 200 bps improvement year-on-year”
Mr. Shashidhar S.K., page 6 of the filed PDF · View the filing
EBITDA margin saturation — 25-27%
stated as an aspiration by Dr. Sampath Ravinarayanan
p. 7
“We expect margins to saturate around 25-27%”
Dr. Sampath Ravinarayanan, page 7 of the filed PDF · View the filing
Revenue recognition of deferred Q4 amount — 142 crores · Q1 and Q2 FY27
stated conditionally by Mr. Shashidhar S.K.
p. 5
“The revenue has moved into FY27 visibility, with recognition expected across Q1 and Q2, subject to delivery, inspection, customer acceptance, and applicable criteria”
Mr. Shashidhar S.K., page 5 of the filed PDF · View the filing
Cash release from land systems WIP — 120 to 140 crores · H1 FY27
stated conditionally by Mr. Shashidhar S.K.
p. 6
“When these deliver, 120 to 140 crores of cash will be released”
Mr. Shashidhar S.K., page 6 of the filed PDF · View the filing
Phase 2 disinvestment — H1 FY27
stated firmly by Dr. Sampath Ravinarayanan
p. 2
“It will happen soon; the strategic rationale is unchanged, the process is active, and it remains a priority for H1 FY27”
Dr. Sampath Ravinarayanan, page 2 of the filed PDF · View the filing
Akkodis transaction closure — Q2 FY27
stated firmly by Mr. Shashidhar S.K.
p. 5
“The transaction is expected to close in Q2 FY27”
Mr. Shashidhar S.K., page 5 of the filed PDF · View the filing
Total capex investment plan — 2,100 to 2,250 crores
stated firmly by Dr. Sampath Ravinarayanan
p. 7
“The total investment plan is between 2,100 to 2,250 crores, which will be totally self-funded through the restructuring phases”
Dr. Sampath Ravinarayanan, page 7 of the filed PDF · View the filing
Equity dilution / debt
stated firmly by Mr. Mukund Santhanam
p. 7
“We have no plans for equity dilution or incremental long-term debt”
Mr. Mukund Santhanam, page 7 of the filed PDF · View the filing
Q&A highlights
Management's answers to analyst questions, in Parakho's words rather than a transcript. Each row names who answered and carries the verbatim quote it was drawn from.
Management said the shift from design to manufacturing naturally produces a 10x to 20x jump in value and reaffirmed the target.
Answered by Dr. Sampath Ravinarayanan
Asked by Nikhil Chandak: Is the FY2030 target of 9,000 crores revenue still organically achievable given the 10x jump required?
p. 6
“We are sticking to the 9,000-crore target; this is a foundational year.”
Dr. Sampath Ravinarayanan, page 6 of the filed PDF · View the filing
Management said core verticals already run at 20%+ EBITDA and targeted further 150-200 bps improvement.
Answered by Mr. Shashidhar S.K.
Asked by Rohan Mehta: Are normalized EBITDA margins moving towards 20% for FY27, and can the order book be quantified?
p. 7
“The non-core verticals were margin-dilutive.”
Mr. Shashidhar S.K., page 7 of the filed PDF · View the filing
Management described the transaction as a slump sale with a one-year handhold period and a guaranteed plus earnout payment structure.
Answered by Mr. Shashidhar S.K.
Asked by Mayur Parkeria: Will the engineering division sale transfer immediately or run until June 2027, and what does the PAT target for FY30 imply?
p. 7
“It is structured as a slump sale to the Akkodis entity in India.”
Mr. Shashidhar S.K., page 7 of the filed PDF · View the filing
Management said Phase 2 disinvestment will fund further expansion and confirmed no dilution plans.
Answered by Dr. Sampath Ravinarayanan
Asked by Jatin Raghuwanshi: How is expansion funded beyond Akkodis cash given negative cash flow, and is there any equity dilution planned?
p. 6
“Phase 2 of the disinvestment is coming very soon and will fund us totally for DAC, DAL, MAC, and our acquisitions.”
Dr. Sampath Ravinarayanan, page 6 of the filed PDF · View the filing
Management described Xida's involvement in data centres and hyperscaler test equipment, and space bus/payload opportunities.
Answered by Dr. Sampath Ravinarayanan
Asked by Suman Gupta: What is the end product and total addressable market for space and hyperscaler businesses?
p. 7
“Xida (formerly ESAI) is involved in data centres and test equipment for hyperscalers and semiconductor giants.”
Dr. Sampath Ravinarayanan, page 7 of the filed PDF · View the filing
Management explained the manufacturing/serial-production model scales revenue automatically and expects margins to saturate at 25-27%.
Answered by Dr. Sampath Ravinarayanan
Asked by Disha: Would reaching 9,000 crores by FY30 require a 90% CAGR from FY28, and could higher EBITDA mean higher PAT than guided?
p. 7
“We expect margins to saturate around 25-27%.”
Dr. Sampath Ravinarayanan, page 7 of the filed PDF · View the filing
Management broke down capex across DAC, MAC, DAL and acquisitions, totaling a self-funded plan.
Answered by Dr. Sampath Ravinarayanan
Asked by Bala Subramanyan: What is the total capex program across facilities and acquisitions?
p. 7
“DAC is 1,200 crores, MAC is 300 crores, and DAL is 120 crores (of which 100 crores is already spent).”
Dr. Sampath Ravinarayanan, page 7 of the filed PDF · View the filing
Risks flagged
Supply chain disruption to a critical input material affected production timelines on a defense manufacturing program
p. 5
“Supply chain disruption to a critical input material affected production timelines on land systems ordered for the Ministry of Defense.”
Mr. Shashidhar S.K., page 5 of the filed PDF · View the filing
A monopolistic hardware supplier redirected output to war-related priority programs, impacting production
p. 5
“A monopolistic hardware supplier redirected output to war-related priority programs, impacting production.”
Mr. Shashidhar S.K., page 5 of the filed PDF · View the filing
Deferment in an aerospace and defense contract arose from the divestment transaction transition
p. 5
“An aerospace and defense contract where deferment arose directly from the divestment transaction transition.”
Mr. Shashidhar S.K., page 5 of the filed PDF · View the filing
Inability to recognize deferred tax assets in a loss-making German entity raised the effective tax rate
p. 6
“we could not recognize deferred tax assets in a loss-making German entity”
Mr. Shashidhar S.K., page 6 of the filed PDF · View the filing
Negative operating cash flow driven by land systems work-in-progress
p. 6
“Negative operating cash flow was driven entirely by 100 crores of land systems WIP, classified under "other assets".”
Mr. Shashidhar S.K., page 6 of the filed PDF · View the filing
Government policy shifts towards Make in India required changes to proposals
p. 7
“government policy shifts towards "Make in India" have required us to change our proposals”
Dr. Sampath Ravinarayanan, page 7 of the filed PDF · View the filing
Generated by claude-sonnet-5. Source: the transcript as filed with BSE. We link to the exchange's copy; we do not host transcripts. Parakho is a data and screening tool, not an investment adviser — nothing here is a recommendation to buy, sell or hold.
Continue reading
- Axiscades Technologies Ltd: filed results and exchange announcements
- Q4 FY26 results for every company Parakho holds
More Q4 FY26 earnings calls, in alphabetical order